Renaissance Technologies
BDTX icon

Renaissance Technologies’s Black Diamond Therapeutics BDTX Stock Holding History

Renaissance Technologies’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.63M Buy
1,962,394
+318,647
+19% +$779K 0.01% 1632
2026
Q1 		$3.5M Buy
1,643,747
+694,012
+73% +$1.65M 0.01% 1571
2025
Q4 		$2.31M Buy
949,735
+350,335
+58% +$1.24M ﹤0.01% 1776
2025
Q3 		$2.27M Buy
599,400
+432,300
+259% +$1.26M ﹤0.01% 1986
2025
Q2 		$414K Buy
167,100
+87,200
+109% +$168K ﹤0.01% 2928
2025
Q1 		$124K Sell
79,900
-824,100
-91% -$1.73M ﹤0.01% 3158
2024
Q4 		$1.93M Buy
904,000
+650,200
+256% +$1.86M ﹤0.01% 2074
2024
Q3 		$1.1M Sell
253,800
-10,100
-4% -$55K ﹤0.01% 2380
2024
Q2 		$1.23M Buy
263,900
+51,300
+24% +$275K ﹤0.01% 2204
2024
Q1 		$1.08M Sell
212,600
-237,800
-53% -$959K ﹤0.01% 2440
2023
Q4 		$1.27M Buy
450,400
+121,500
+37% +$285K ﹤0.01% 2245
2023
Q3 		$944K Buy
328,900
+108,200
+49% +$399K ﹤0.01% 2352
2023
Q2 		$1.11M Buy
220,700
+3,200
+1% +$6.54K ﹤0.01% 2405
2023
Q1 		$411K Sell
217,500
-3,113
-1% -$7.15K ﹤0.01% 2981
2022
Q4 		$397K Buy
220,613
+2,913
+1% +$5.25K ﹤0.01% 3086
2022
Q3 		$368K Sell
217,700
-54,302
-20% -$167K ﹤0.01% 3099
2022
Q2 		$669K Buy
272,002
+7,511
+3% +$17.5K ﹤0.01% 2973
2022
Q1 		$733K Sell
264,491
-120,909
-31% -$441K ﹤0.01% 2932
2021
Q4 		$2.05M Buy
+385,400
New +$2.69M ﹤0.01% 2119
2021
Q2 		– Sell
-18,600
Closed -$451K – 3455
2021
Q1 		$451K Buy
+18,600
New +$502K ﹤0.01% 2942
2020
Q3 		– Sell
-26,507
Closed -$1.12M – 3376
2020
Q2 		$1.12M Buy
+26,507
New +$976K ﹤0.01% 2490

Other funds holding BDTX

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Defilade Capital Management Emeryville, California $747M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Renaissance Technologies's BDTX Position: Q2 2026 in Review

Renaissance Technologies increased its Black Diamond Therapeutics (BDTX) stake by 19% in Q2 2026, buying an estimated $779K and bringing the position to 1,962,394 shares worth $3.63M. The position accounts for 0.01% of the portfolio, ranked #1632.

Renaissance Technologies first reported a position in BDTX in Q2 2020 and has held it in 21 quarters since. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Renaissance Technologies held 1,962,394 shares of Black Diamond Therapeutics worth $3.63M as of Q2 2026.
  • Renaissance Technologies bought 318,647 Black Diamond Therapeutics shares in Q2 2026, an estimated $779K.
  • Black Diamond Therapeutics made up 0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1632 holding.
  • Renaissance Technologies first reported a position in Black Diamond Therapeutics in Q2 2020 and has held it in 21 quarters since.
  • 96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.